The relaxant effect of sex steroids in rat myometrium is independent of the gamma-amino butyric acid system

Life Sciences

Volumn 58, Issue 11, 1996, Pages 913-926

  Perusquía, Mercedes ^a,c   Villalón, Carlos M ^b  

^a UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

^b DEPARTAMENTO DE FÍSICA   (Mexico)

^c INSTITUTO DE INVESTIGACIONES BIOMÉDICAS   (Mexico)

Author keywords

Androgens; GABA; Progestins; Steroid action; Steroids; Uterine relaxants

Indexed keywords

3ALPHA HYDROXY 5ALPHA PREGNAN 20 ONE; 3BETA HYDROXY 5BETA PREGNAN 20 ONE; 4 AMINOBUTYRIC ACID; 4 AMINOBUTYRIC ACID A RECEPTOR; 4 AMINOBUTYRIC ACID A RECEPTOR STIMULATING AGENT; 5ALPHA PREGNANE 3,20 DIONE; 5BETA ANDROSTANOLONE; ANDROSTANEDIOL; ANDROSTERONE; BICUCULLINE METHIODIDE; ELTANOLONE; ESTRADIOL; GABAERGIC RECEPTOR AFFECTING AGENT; MUSCIMOL; POTASSIUM CHLORIDE; PREGNANEDIONE; PROGESTERONE; SEX HORMONE; TESTOSTERONE; TETRAHYDROPROGESTERONE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CALCIUM TRANSPORT; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG MECHANISM; ESTRUS CYCLE; FEMALE; GABAERGIC SYSTEM; MUSCLE ISOMETRIC CONTRACTION; MYOMETRIUM; NONHUMAN; PREGNANCY; RAT; SUBCUTANEOUS DRUG ADMINISTRATION; UTERUS RELAXATION;

EID: 0029966612     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/0024-3205(96)00034-3     Document Type: Article

References (45)

1. E.E. BALIEU, F. GODEAU, M. SCHORDERET and S. SHORDERET-SLATHRINE, Nature 275 593-598 (1978).
2. L. GYERMEK and L.F. SOYKA, Anaesthesiology 42 331-334 (1975).
3. M. HOLZBAUER, Med. Biol. 54 227-242 (1976).
4. C. KUBLI-GARFIAS, L. MEDRANO-CONDE, C. BEYER and A. BONDANI, Steroids 34 609-617 (1979).
5. C. KUBLI-GARFIAS, A. LÓPEZ-FIESCO, M.T. PACHECO, H. PONCE-MONTER and A. BONDANI, Steroids 35 633-641 (1980).
6. C. KUBLI-GARFIAS, C. HOYO-VADILLO, E. LÓPEZ-NIETO and H. PONCE-MONTER, Proc. West. Pharmacol. Soc. 26 115-118 (1983).
7. C. KUBLI-GARFIAS, J. Steroid Biochem. 27 631-634 (1987).
8. M. MAJEWSKA, N. HARRISON, R. SCHWARTZ, J. BAKER and S.M. PAUL, Science 236 923-930 (1986).
9. M.A. SIMMONDS and J.P. TURNER, Neuropharmacology 26 923-930 (1987).
10. K. GEE, M. BOLGER, R. BRINTON, H. CORINI and B. McEWEN, J. Pharmacol. Exp. Ther. 246 803-812 (1988).
11. M. PERUSQUÍA, E. GARCÍA-YAÑEZ, R. IBANEZ and C. KUBLI-GARFIAS, Life Sci. 47 1547-1553 (1990).
12. A.I. FERNÁNDEZ, V. MARTÍNEZ, B. CANTABRANA and A. HIDALGO, Gen. Pharmacol. 23(3) 549-554 (1992).
13. J.A. SÁNCHEZ-APARICIO, B. CANTABRANA and A. HIDALGO, Gen. Pharmacol. 23(4) 643-647 (1992).
14. M. PERUSQUÍA and G. CAMPOS, Med. Sci. Res. 19 177-179 (1991).
15. M. PERUSQUÍA, G. CAMPOS, J.L. CORONA and C. KUBLI-GARFIAS, Proc. West. Pharmacol. Soc. 34 395-398 (1991).
16. M. PERUSQUÍA, J.L. CORONA and C. KUBLI-GARFIAS, Proc. West. Pharmacol. Soc. 34 89-92 (1991).
17. M. PERUSQUÍA and C. KUBLI-GARFIAS, Prostaglandins 43 445-455 (1992).
18. S.L. ERDÖ, B. ROSDY and L. SZPORNY, J. Neurochem. 38 1174-1176 (1982).
19. J.A. APUD, M.L. TOPPAZ, F. CALOTTI, P. NEGRI-CESI, C. MASOTTO and G. RACAGNI, J. Neurochem. 43 120-125 (1984).
20. S.L. ERDÖ and E. LAPIS, Eur. J. Pharmacol. 85 243-246 (1982).
21. J.M. SCHAEFFER and A.J. HSUEH, Life Sci. 30 1599-1604 (1982).
22. R.M. DEL RIO and A.L. CABALLERO, J. Neurochem. 34 1584-1586 (1984).
23. S.L. ERDÖ, Biochem. Biophys. Res. Commun. 125 18-24 (1984).
24. S.L. ERDÖ, A. LASZLO, B. KISS and B. ZSOLNAI, Gynecol. Obstet. Invest. 20 199-203 (1985).
25. M.D. MEJEWSKA and D.B. VAUPEL, J. Endocrinol. 131 427-434 (1991).
26. C.D. PUTNAM, D.W. CRANN, R.C. KOLBECK and V.B. MAHESH, Biol. Reprod. 45 266-272 (1991).
27. N. PENCHEVA, R. RADOMIROV and K. VENKOVA, Gen. Pharmacol. 22 159-163 (1991).
28. J.T. LITCHFIELD and F.A. WILCOXON, J. Pharmacol. Exp. Ther. 96 99-108 (1949).
29. R. MARTIN DEL RIO, J. Biol. Chem. 256 9816-9819 (1981).
30. J. FERNÁNDEZ-PARDAL, M.F. GIMENO and A.L. GIMENCO, IRCS. Med. Sci. 12 706 (1984).
31. M. RIESZ and S.L ERDÖ, Eur. J. Pharmacol. 119-204 (1985).
32. G. MAKSAY, J. Neurochem. 50 1865-1871 (1988).
33. Z.W. ZHANG and P. FELTZ, Bri. J. Pharmacol. 102 19-22 (1991).
34. A. KRANTIS, M. COSTA, J.B. FURNESS and J. ORBACH, Eur. J. Pharmacol. 67 461-468 (1980).
35. K.R. JESSEN, R. MIRSKY and J.M. HILLS, TINS 10 255-262 (1987).
36. M.D. MAJEWSKA, G. FALKAY and E.E. BAULIEU, Eur. J. Pharmacol. 174 43-47 (1989).
37. L.M. ORENSANZ, C. AZURA and I. FERNÁNDEZ, Neurosci. Lett. 57 213-214 (1985).
38. S.L. ERDÖ, GABAergic mechanisms in the mammalian periphery, S.L. Erdö and N.G. Bowery (Eds), 205-222, .Raven Press; New York (1986).
39. A. KLOPPER and E.M. MICHIE, J. Endocrinol. 13 369-373 (1956).
40. S. SOLOMON, C.E. BIRD, W. LING, M. IWAMIYA and P.C.M. YOUNG, Rec. Prog. Horm. Res. 23 297-403 (1967).
41. A.B. LITTLE and R.B. BILLAR, Endocrinology of Pregnancy, F. Fuchs and A. Klopper (Eds), 92-111, Harper & Row, Philadelphia (1983).
42. M. PERUSQUÍA and C. KUBLI-GARFIAS, Life Sci. 54(20) 1501-1506 (1994).
43. J.M.H. FFRENCH-MULLEN and K.T. SPENCE, Eur. J. Pharmacol. 202 269-272 (1991).
44. J.M.H. FFRENCH-MULLEN, P. DANKS and K.T. SPENCE, J. Neuroscience 14(4) 1963-1977 (1994).
45. P. SEEMAN, Pharmacol. Rev. 24 583-655 (1972).